Johnson and Johnson
Also known as: Alisyn Facemire | Caroff, Stanley N., M.D. | CENTOCOR ORTHO BIOTECH INC | Cerenovus, Part of DePuy Synthes Products, Inc. | Jan-Cil Italy | Jan-Cil Spain | Jan-Cil Switzerland | Jan-Cil UK | J AND J | J AND J CONSUMER INC | Jannsen Research & Development, LLC | Janssen Alzheimer Immunotherapy (JAI) Research and Development, LLC | JANSSEN Alzheimer Immunotherapy Research & Development, LLC | JANSSEN BIOTECH | Janssen (China) Research & Development Center | Janssen-Cilag A.G. | Janssen-Cilag B.V. | Janssen-Cilag div. of Johnson&Johnson SE | Janssen-Cilag Farmaceutica Ltda. | Janssen-Cilag Farmaceutica, S.R.L. | Janssen-Cilag G.m.b.H | Janssen-Cilag International NV | Janssen-Cilag Limited | Janssen-Cilag Ltd. | Janssen-Cilag Ltd.,Thailand | Janssen-Cilag Pharmaceutica S.A.C.I. | Janssen-Cilag Pty Ltd | Janssen-Cilag, S.A. | Janssen-Cilag S.p.A. | Janssen-Cilag Taiwan | Janssen-Cilag Tibotec | Janssen-Cilag Turkey | Janssen-Cilag VIETNAM | JANSSEN LP | JANSSEN PHARMA | Janssen Pharmaceuticals (collaborator) | JANSSEN PRODS | JANSSEN R AND D | JANSSEN RES AND DEV | Janssen Research and Developement, LLC | Janssen Research and Development | Janssen Research and Development LLC | Janssen Research & Development, LLC | JANSSEN THERAP | Janssen World Without Disease Accelerator (WWDA) Healthy Baby Initiative (HBI) | J&J Consumer and Personal Products Worldwide | Johnson and Johnson, | JOHNSON AND JOHNSON | Johnson and Johnson Consumer, Inc | Johnson and Johnson Medical Korea Ltd | Johnson & Johnson | Johnson & Johnson Consumer and Personal Products Worldwide | Johnson & Johnson Consumer Inc. (J&JCI) | Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division | Johnson & Johnson Consumer & Personal Products Companies, Inc. | Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc. | Johnson & Johnson Enterprise Innovation Inc. | Johnson & Johnson GmbH | Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. | Johnson & Johnson (Hong Kong) Ltd. | Johnson & Johnson K.K. Medical Company | Johnson & Johnson Medical, China | Johnson & Johnson Pharmaceutical R&D, L.L.C | Johnson & Johnson Pharmaceutical Research and Development, LLC | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Johnson & Johnson Private Limited | Johnson & Johnson Pte Ltd | Johnson & Johnson Surgical vision | Johnson & Johnson Surgical Vision, Inc. | Johnson & Johnson Taiwan Ltd | Johnson & Johnson Vision Care, Inc. | JOHNSON JOHNSON VISN | McNeil AB | OMJ Pharmaceuticals | OMJ PHARMACEUTICALS | Ortho Biotech Oncology Research & Development - Unit of Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Ortho Dermatologics | Ortho-McNeil | ORTHO MCNEIL | Ortho-McNeil, Inc. | ORTHO MCNEIL JANSSEN | Ortho-McNeil Janssen Scientific Affairs, LLC | Ortho-McNeil Neurologics, Inc. | ORTHO MCNEIL PHARM | Ortho-McNeil Pharmaceutical | PriCara | PriCara, Unit of Ortho-McNeil, Inc. | R&D MedClin EMEA, J&J | R W Johnson Pharmaceutical Research Institute | Shanghai Johnson & Johnson Pharmaceuticals | Shanghai Johnson & Johnson Pharmaceuticals, Ltd. | SOLA BARNES HIND | Stanley Caroff N., M.D. | Xian-Janssen Pharmaceutical Ltd.
Highest phase reached
Phase 4
First clinical trial
Jun 1, 1931First marketed drug
Sep 12, 1945First NDA
Sep 12, 1945Last known activity
Mar 17, 2026
Timeline
1880s
- Jan 1, 1886
Johnson and Johnson— Founded
1940s
- Jun 1, 1949
Ethicon— Acquired
1950s
- Jan 1, 1959
Cilag Chemie AG— Acquired
- Jan 1, 1959
McNeil— Acquired
1960s
- Jan 1, 1961
Janssen Pharmaceutica NV— Acquired
1980s
- Jun 1, 1981
Vistakon Pharmaceuticals— Acquired
- Jun 1, 1986
LifeScan— Acquired
1990s
- Jun 1, 1993
Ortho Pharmaceuticals— Acquired
- Jan 1, 1994
Neutrogena— Acquired
- Apr 28, 1995
famotidine— NDA Secondary Org
- Jan 1, 1996
Cordis— Acquired
- Sep 29, 1997
Biosense Webster, Inc.— Acquired
- Jul 21, 1998
DePuy— Acquired
- Jan 1, 1999
Centocor— Acquired
2000s
- Jan 1, 2001
Alza— Acquired
- Jan 1, 2002
Tibotec— Acquired
- Jun 1, 2002
OraPharma— Acquired
- Jan 1, 2003
Scios— Acquired
- Jan 1, 2005
Peninsula Pharmaceuticals— Acquired
- Dec 16, 2005
Animas Corporation— Acquired
- Jan 1, 2008
HealthMedia— Acquired
- Jan 1, 2008
Omrix Biopharmaceuticals, Inc.— Acquired
- Jan 1, 2009
Cougar Biotechnology— Acquired
- Jan 23, 2009
Mentor Worldwide, LLC— Acquired
2010s
- Jan 1, 2010
Crucell— Acquired
- Jan 1, 2011
Acclarent— Acquired
- Apr 27, 2011
Stratec Medical— Acquired
- Jan 1, 2012
Calibra Medical— Acquired
- Jun 24, 2012
Corimmun GmbH— Acquired
- Jan 1, 2013
Aragon Pharmaceuticals— Acquired
- Sep 30, 2014
Alios BioPharma— Acquired
- Jan 1, 2015
Novirio Therapeutics— Acquired
- Jan 1, 2015
X01— Acquired
- Sep 26, 2015
NeoStrata Company, Inc.— Acquired
- Nov 1, 2015
Novira Therapeutics, Inc.— Acquired
- Nov 20, 2015
Coherex Medical— Acquired
- Jan 1, 2017
Vascular Pharmaceuticals, Inc.— Acquired
- Jun 16, 2017
Actelion— Acquired
- Jul 30, 2018
Zarbee's Inc.— Acquired
- Feb 13, 2019
Auris Medical— Acquired
- Apr 12, 2019
erdafitinib— Marketing Organization
- Apr 12, 2019
erdafitinib— NDA Organization
- Oct 23, 2019
Ci:z Holdings— Acquired
2020s
- Jun 19, 2020
Momenta Pharmaceuticals— Acquired
- Nov 1, 2022
Abiomed Inc.— Acquired
- Nov 30, 2023
Laminar Pharmaceuticals— Acquired
- Jan 8, 2024
Ambrx— Acquired
- Jan 13, 2025
Intra-Cellular Therapies— Acquired
- Nov 17, 2025
Halda Therapeutics OpCo, Inc.— Acquired
Drugs by trial phase (862 distinct, 3424 trials)
Phase 4 (36 own, 150 via acquisition)
Phase 3 (47 own, 144 via acquisition)
Phase 2 (50 own, 182 via acquisition)
Phase 1 (83 own, 140 via acquisition)
Indications
Approved for
- Acute Pain
- Aggression
- Alzheimer Disease
- Ancylostomiasis
- Anorexia Nervosa
- Arthritis, Psoriatic
- Arthritis, Rheumatoid
- Aspergillosis
- Attention Deficit Disorder with Hyperactivity
- Autistic Disorder
- Bacterial Infections
- Bipolar Disorder
- Borderline Personality Disorder
- Bronchitis, Chronic
- Candidiasis, Oral
- Candidiasis, Vulvovaginal
- Castleman Disease
- Cholecystitis
- Chronic Pain
- Colitis, Ulcerative
- Colonic Neoplasms
- Conduct Disorder
- Conjunctivitis, Bacterial
- Corneal Ulcer
- Cystitis
- Cystitis, Interstitial
- Diabetes Mellitus, Type 2
- Diarrhea
- Enterobiasis
- Epilepsy
- Frontotemporal Dementia
- Hepatitis C, Chronic
- Histoplasmosis
- HIV-1
- HIV Infections
- Ileus
- Infections
- Intestinal Obstruction
- Intraabdominal Infections
- Leiomyosarcoma
- Liposarcoma
- Major Depressive Disorder
- Migraine Disorders
- Necatoriasis
- Neuralgia
- Onychomycosis
- Osteoarthritis
- Otitis
- Ovarian Neoplasms
- Pain
- Plague
- Pneumonia
- Pregnancy
- Prostatic Neoplasms
- Prostatic Neoplasms, Castration-Resistant
- Prostatitis
- Psoriasis
- Psychotic Disorders
- Pulmonary Embolism
- Pyelonephritis
- Rhinitis, Allergic, Perennial
- Rhinitis, Allergic, Seasonal
- Schizophrenia
- Spondylitis, Ankylosing
- Staphylococcal Skin Infections
- Tics
- Tourette Syndrome
- Trichuriasis
- Tuberculosis
- Tuberculosis, Multidrug-Resistant
- Urethritis
- Urinary Bladder, Neurogenic
- Urinary Bladder, Overactive
- Urinary Tract Infections
- Urticaria
Studied for
- Abdomen, Acute
- Abdominal Abscess
- Abdominal Pain
- Abscess
- Acalculous Cholecystitis
- Acne Vulgaris
- Acquired Immunodeficiency Syndrome
- Acute Coronary Syndrome
- Acute Disease
- Acute Pain
- Adenocarcinoma
- Adenomatous Polyposis Coli
- Adnexal Diseases
- Adrenal Hyperplasia, Congenital
- Adrenogenital Syndrome
- Affective Disorders, Psychotic
- Albuminuria
- Alcoholism
- Alopecia
- Alopecia Areata
- Alzheimer Disease
- Amebiasis
- Amyloidosis
- Anemia
- Anemia, Sickle Cell
- Angina, Unstable
- Ankle Injuries
- Anxiety Disorders
- Aphasia, Primary Progressive
- Apnea
- Appendicitis
- Arthralgia
- Arthritis
- Arthritis, Juvenile
- Arthritis, Psoriatic
- Arthritis, Rheumatoid
- Asperger Syndrome
- Aspergillosis
- Asthma
- Atrial Fibrillation
- Atrial Flutter
- Atrophy
- Attention Deficit and Disruptive Behavior Disorders
- Attention Deficit Disorder with Hyperactivity
- Autism Spectrum Disorder
- Autistic Disorder
- Autoimmune Diseases
- Back Pain
- Bacteremia
- Bacterial Infections
- Bacteriuria
- Basal Cell Carcinoma
- Behcet Syndrome
- Binge-Eating Disorder
- Bipolar Disorder
- Blastomycosis
- Body Weight Changes
- Brain Diseases
- Brain Injuries
- Brain Injuries, Traumatic
- Breakthrough Pain
- Breast Diseases
- Breast Neoplasms
- Bronchitis
- Bronchitis, Chronic
- Bulimia
- Burkitt Lymphoma
- Burns
- Burns, Electric
- Cancer Pain
- Candidiasis
- Candidiasis, Vulvovaginal
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Small Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Cardiovascular Diseases
- Castleman Disease
- Cellulitis
- Central Nervous System Diseases
- Cerebral Infarction
- Child Behavior Disorders
- Child Development Disorders, Pervasive
- Cholangiocarcinoma
- Cholecystitis
- Chronic Disease
- Chronic Pain
- Cluster Headache
- Cognition Disorders
- Cognitive Dysfunction
- Coinfection
- Colitis
- Colitis, Ulcerative
- Collagen Diseases
- Colorectal Neoplasms
- Common Cold
Marketed drugs (121)
Subsidiaries (45 direct, 60 total across the full acquisition tree)
- Abiomed Inc.
- Acclarent
- Actelion
- Alios BioPharma
- Alza
- Ambrx
- Animas Corporation
- Aragon Pharmaceuticals
- Auris Medical
- Biosense Webster, Inc.
- Calibra Medical
- Centocor
- Cilag Chemie AG
- Ci:z Holdings
- Coherex Medical
- Cordis
- Corimmun GmbH
- Cougar Biotechnology
- Crucell
- DePuy
- Ethicon
- Halda Therapeutics OpCo, Inc.
- HealthMedia
- Intra-Cellular Therapies
- Janssen Pharmaceutica NV
- Laminar Pharmaceuticals
- LifeScan
- McNeil
- Mentor Worldwide, LLC
- Momenta Pharmaceuticals
- NeoStrata Company, Inc.
- Neutrogena
- Novira Therapeutics, Inc.
- Novirio Therapeutics
- Omrix Biopharmaceuticals, Inc.
- OraPharma
- Ortho Pharmaceuticals
- Peninsula Pharmaceuticals
- Scios
- Stratec Medical
- Tibotec
- Vascular Pharmaceuticals, Inc.
- Vistakon Pharmaceuticals
- X01
- Zarbee's Inc.
- Axovan AG L2
- Ceptaris L2
- ChromaGenics L2
- CoTherix L2
- Covagen L2
- Introgene L2
- Ortho Biotech, Inc. L2
- RespiVert L2
- Sequus Pharmaceuticals L2
- Swiss Serum Institute L2
- Synthes L2
- Torax Medical Incorporated L2
- Trasir Therapeutics L2
- U-Bisys L2
- XO1 L2
Recent trials (50)
- NCT03834376Lead sponsorN/A—
- NCT03945903Lead sponsorN/A—
- NCT03945903Study directorN/A—
- NCT03829579Lead sponsorN/A—
- NCT07310095Lead sponsorPhase 4Jan 16, 2026
- NCT07032714CollaboratorPhase 1Dec 16, 2025
- NCT07219212OfficialPhase 1Dec 11, 2025
- NCT07219212Lead sponsorPhase 1Dec 11, 2025
- NCT07110662CollaboratorPhase 1/Phase 2Oct 29, 2025
- NCT07075510CollaboratorPhase 1/Phase 2Oct 23, 2025
- NCT06993675CollaboratorPhase 2Aug 21, 2025
- NCT07141004Lead sponsorPhase 4Aug 12, 2025
- NCT07105059CollaboratorPhase 1Aug 8, 2025
- NCT07030517OfficialPhase 4May 22, 2025
- NCT07030517Lead sponsorPhase 4May 22, 2025
Details
- Founded
- New Brunswick, New Jersey, US Jan 1, 1886
- First NDA
- Sep 12, 1945
- Last known activity
- Mar 17, 2026
Designations held
- Orphan drug
- Fast track
- Priority review
- Breakthrough therapy
- Accelerated approval